Clinical Trials · NCT00471237
A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- GlaxoSmithKline
- Enrollment
- 564
- Start date
- May 2007
- Locations
- 49 sites, 14 countries
- Primary endpoint
- Percent Change From Baseline in Bone Marrow Density (BMD) at Month 12 Measured by Dual-Energy X-Ray Absorptiometry (DXA) Scans of the Lumbar Spine (L1-L4)